This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Ancureall Pharmaceutical (Shanghai) Co., Ltd.. Active years: 2019-2022.
Location History:
- Pudong, CN (2019)
- Shanghai, CN (2022)
Company Filing History:
Years Active: 2019-2022
Title: Chentao Zhou: Innovator in Pharmaceutical Chemistry
Introduction
Chentao Zhou is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific biological pathways. With a total of 2 patents, Zhou's work is focused on innovative solutions for treating diseases, including cancer.
Latest Patents
Zhou's latest patents include a histone methyltransferase EZH2 inhibitor, which is designed to treat diseases associated with the histone methyltransferase EZH2, especially cancer. This invention encompasses a compound represented by a specific general formula, along with its preparation method and pharmaceutical applications. Another notable patent is for an acrylanilide derivative, which is used in pharmacy for treating clinical diseases by acting on EGFR family casein kinases. These inventions highlight Zhou's commitment to advancing medical science through innovative drug development.
Career Highlights
Chentao Zhou is currently employed at Ancureall Pharmaceutical (Shanghai) Co., Ltd. His role at the company allows him to leverage his expertise in pharmaceutical chemistry to contribute to the development of new therapeutic agents. Zhou's work is characterized by a strong focus on research and innovation, which has positioned him as a key figure in his field.
Collaborations
Zhou collaborates with several talented individuals in his field, including Jutong Si and Guan Zhong Wang. These collaborations enhance the research environment and foster the exchange of ideas, leading to more innovative solutions in pharmaceutical development.
Conclusion
Chentao Zhou is a dedicated inventor whose work in pharmaceutical chemistry is making a significant impact on the treatment of diseases. His innovative patents and collaborations reflect his commitment to advancing medical science and improving patient outcomes.